联合使用蒙特利尔认知评估与符号数字模态测验提高心脏骤停后神经认知筛查准确性:TTM2试验验证子研究
该研究为TTM2试验验证子研究,纳入108例院外心脏骤停幸存者(中位年龄62岁,88%男性),在6个月时评估MoCA、SDMT、TSQ和IQCODE-CA四种神经认知筛查工具,以全面神经心理测验组合为金标准。结果显示MoCA(敏感性0.64,特异性0.85)和SDMT(敏感性0.59,特异性0.83)的分类准确性高于TSQ(敏感性0.28,特异性0.74)和IQCODE-CA(敏感性0.42,特异性0.60)。联合使用MoCA或SDMT的切点识别神经认知障碍时敏感性提高至0.81,特异性0.74,曲线下面积0.77(95%CI 0.69-0.85)。未识别的损害最常见于情景记忆和执行功能域,联合筛查假阴性病例较少。结论认为MoCA和SDMT对院外心脏骤停人群神经认知障碍筛查具有可接受的诊断准确性,联合使用可提高敏感性,而患者和观察者报告与神经认知表现对应不佳。
要点
- 联合使用MoCA<26或SDMT z≤-1筛查时敏感性0.81、特异性0.74,AUC 0.77(95%CI 0.69-0.85),优于任一单项。
- 单项MoCA<26敏感性0.64、特异性0.85;SDMT z≤-1敏感性0.59、特异性0.83,分类准确性高于TSQ和IQCODE-CA。
- 患者自报TSQ敏感性仅0.28、特异性0.74;观察者报告IQCODE-CA≥3.04敏感性0.42、特异性0.60,与神经认知表现对应不佳。
- 未识别的损害最常见于情景记忆和执行功能域,联合MoCA或SDMT后假阴性病例较少。
- 筛查在心脏骤停后6个月进行,以全面神经心理测验组合为金标准。
适用人群与场景
- 院外心脏骤停(OHCA)幸存者,来自TTM2试验子研究,共108例,中位年龄62岁,88%男性。
- 神经认知筛查在心脏骤停后6个月时进行。
诊断标准与关键阈值
- MoCA(蒙特利尔认知评估)切点:<26。
- SDMT(符号数字模态测验)切点:z≤-1。
- IQCODE-CA(心脏骤停版老年人认知衰退知情者问卷)切点:≥3.04。
- 联合筛查标准:使用MoCA或SDMT的切点组合识别神经认知障碍。
研究设计与关键结果
- 研究类型:TTM2试验验证子研究,以全面神经心理测验组合为金标准评估神经认知筛查工具的敏感性和特异性。
- 人群:108例OHCA幸存者,中位年龄62岁,88%男性,筛查在6个月时进行。
- 单项工具诊断准确性:MoCA<26敏感性0.64、特异性0.85;SDMT z≤-1敏感性0.59、特异性0.83;TSQ敏感性0.28、特异性0.74;IQCODE-CA≥3.04敏感性0.42、特异性0.60。
- MoCA和SDMT分类准确性高于TSQ和IQCODE-CA。
- 联合使用MoCA或SDMT切点:敏感性0.81、特异性0.74,AUC 0.77(95%CI 0.69-0.85)。
- 未识别的损害最常见于情景记忆和执行功能域,联合MoCA或SDMT后假阴性病例较少。
- 患者和观察者报告与神经认知表现对应不佳。
证据类型、等级与局限
- 证据类型:TTM2试验验证子研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为MoCA和SDMT对OHCA人群神经认知障碍筛查具有可接受的诊断准确性,联合使用可提高敏感性。
- 患者自报TSQ和观察者报告IQCODE-CA与神经认知表现对应不佳,不宜单独用于筛查。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To assess the merit of clinical assessment tools in a neurocognitive screening following out-of-hospital cardiac arrest (OHCA).
METHODS: The neurocognitive screening that was evaluated included the performance-based Montreal Cognitive Assessment (MoCA) and Symbol Digit Modalities Test (SDMT), the patient-reported Two Simple Questions (TSQ) and the observer-reported Informant Questionnaire on Cognitive Decline in the Elderly-Cardiac Arrest (IQCODE-CA). These instruments were administered at 6-months in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. We used a comprehensive neuropsychological test battery from a TTM2 trial sub-study as a gold standard to evaluate the sensitivity and specificity of the neurocognitive screening.
RESULTS: In our cohort of 108 OHCA survivors (median age = 62, 88% male), the most favourable cut-off scores were: MoCA < 26; SDMT z ≤ -1; IQCODE-CA ≥ 3.04. The MoCA (sensitivity 0.64, specificity 0.85) and SDMT (sensitivity 0.59, specificity 0.83) had a higher classification accuracy than the TSQ (sensitivity 0.28, specificity 0.74) and IQCODE-CA (sensitivity 0.42, specificity 0.60). When using the cut-points for MoCA or SDMT in combination to identify neurocognitive impairment, sensitivity improved (0.81, specificity 0.74), area under the curve = 0.77, 95% CI [0.69, 0.85]. The most common unidentified impairments were within the episodic memory and executive functions domains, with fewer false negative cases on the MoCA or SDMT combined.
CONCLUSION: The MoCA and SDMT have acceptable diagnostic accuracy for screening for neurocognitive impairment in an OHCA population, and when used in combination the sensitivity improves. Patient and observer-reports correspond poorly with neurocognitive performance.
CLINICALTRIALS: gov Identifier: NCT03543371.
参考来源
- Blennow Nordström E, Evald L, Mion M, et al. Combined use of the Montreal Cognitive Assessment and Symbol Digit Modalities Test improves neurocognitive screening accuracy after cardiac arrest: A validation sub-study of the TTM2 trial. Resuscitation. 2024. PMID: 39147306. doi:10.1016/j.resuscitation.2024.110361
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。